White paperThe Enterprise Framework for Compliant, Scalable AI
Download now
Continuous complianceDataRegulations

Pharmaceutical Company Transitions to CSA Model with USDM Expertise

Learn how USDM helped a pharmaceutical company achieve greater efficiencies in their validation process through a hybrid CSA model for testing.

Client profile: Large pharmaceutical company focused on research, development, and manufacturing across dermatology, oncology, and specialty injectable therapeutic areas.

Pharmaceutical Company Transitions to CSA Model with USDM Expertise graphic

Executive takeaway

USDM re-engineered a pharmaceutical company's cumbersome CSV process into a hybrid Computer Software Assurance (CSA) model, significantly reducing scripted tests and documentation time so teams could refocus on critical, risk-based testing.

Scripted Tests

Significantly reduced

USDM cut the number of scripted tests required in the company's validation processes by shifting to a risk-based CSA approach.

Mindset Shift

Documentation-focused to testing-focused

The true risk-based CSA methodology refocused teams away from excessive documentation and toward critical testing activities.

Standardized Procedures

Company-wide

USDM created comprehensive, standardized SOPs and templates and trained internal teams — now the basis for CSV at the company.

Before USDM

  • A cumbersome, traditional CSV process in place for validation
  • Validation activities that were time-consuming and required an excessive amount of documentation
  • Internal SOPs and templates that slowed testing and tied up engineering time

After USDM

  • A hybrid Computer Software Assurance (CSA) model built on a true risk-based approach
  • Significantly fewer scripted tests and less time spent documenting procedures
  • Standardized procedures, refreshed SOPs and templates, and trained internal teams — now the basis for CSV at the company

Greater validation efficiency through a hybrid CSA model

USDM worked in collaboration with a large pharmaceutical company to update its internal validation processes and enhance the efficiency of its testing activities. With USDM's expertise and assistance, the company moved away from a traditional Computer System Validation (CSV) model to a new hybrid Computer Software Assurance (CSA) model.

The Challenge

The client is a pharmaceutical company focused on research, development, and manufacturing — primarily across dermatology, oncology, and specialty injectable therapeutic areas. Its validation program had become a bottleneck:

  • A cumbersome, traditional CSV process was in place for validation
  • Validation activities were time-consuming and required an excessive amount of documentation
  • Heavy scripted testing and paperwork pulled engineering time away from critical testing

The company needed a leaner, risk-based path that still held up to 21 CFR Part 11 expectations and protected data integrity across its computerized systems.

The Approach

USDM partnered with the company's internal team to re-work its entire validation structure and shift to a true risk-based methodology:

  • Moved the company's internal processes from traditional Computer System Validation (CSV) to a hybrid Computer Software Assurance (CSA) process
  • Helped the company recreate internal SOPs and templates to gain efficiencies
  • Built comprehensive, standardized procedures for the company's testing activities and trained internal teams to own them

This work reframed validation as an ongoing, risk-prioritized discipline rather than a documentation exercise — the same principle behind USDM's broader continuous compliance approach.

The Results

  • The company significantly reduced the number of scripted tests in its validation processes
  • It reduced the time spent documenting procedures, freeing up more time for critical testing
  • USDM delivered comprehensive, standardized procedures for the company's testing activities and trained internal teams to sustain them

The draft procedures and tools USDM collaborated on are now the basis for CSV at the company.

In the client's words

“USDM provided a great framework for re-aligning our cumbersome CSV process to adopt the CSA methodology. Their experience and insight on this true risk-based approach really helped shift mindsets from documentation-focused to testing-focused. The draft procedures and tools they collaborated with us on are now the basis for CSV at our company.” – Process & Project Development Engineer

Validation that works the way your teams do

By replacing a documentation-heavy CSV process with a hybrid, risk-based CSA model, USDM helped this pharmaceutical company spend less time on paperwork and more time on the testing that actually reduces risk. To see how a risk-based CSA approach could streamline your validation, talk with USDM's CSA experts.

Computer Software Assurance

Move from CSV burden to risk-based CSA

Like this pharmaceutical company, your teams can spend less time documenting and more time on critical testing. USDM's CSA experts help you re-engineer validation around a true risk-based approach.

Explore CSA with USDM

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.